Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine

Reversible acetylcholinesterase inhibitors are used as first-line treatment for myasthenia gravis. They improve symptoms by increasing concentration of acetylcholine at the neuromuscular junction and stimulating nicotinic receptors. Serious bradyarrhythmias can occur from muscarinic stimulation in h...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Saud Khan, Abhinav Tiwari, Zubair Khan, Himani Sharma, Mohammad Taleb, Jeffrey Hammersley
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2017/6956298
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554462533648384
author Mohammad Saud Khan
Abhinav Tiwari
Zubair Khan
Himani Sharma
Mohammad Taleb
Jeffrey Hammersley
author_facet Mohammad Saud Khan
Abhinav Tiwari
Zubair Khan
Himani Sharma
Mohammad Taleb
Jeffrey Hammersley
author_sort Mohammad Saud Khan
collection DOAJ
description Reversible acetylcholinesterase inhibitors are used as first-line treatment for myasthenia gravis. They improve symptoms by increasing concentration of acetylcholine at the neuromuscular junction and stimulating nicotinic receptors. Serious bradyarrhythmias can occur from muscarinic stimulation in heart, which in rare cases may progress to asystole. These patients can initially be managed with hyoscyamine, a muscarinic antagonist. Persistence of bradyarrhythmias even after hyoscyamine treatment may warrant pacemaker placement. We present a case of 65-year-old female patient who presented with diplopia, dysphagia, and muscle weakness who was diagnosed with myasthenia gravis. She developed significant sinoatrial node block with prolonged asystole after starting treatment with pyridostigmine which was successfully treated with hyoscyamine, thus avoiding pacemaker placement.
format Article
id doaj-art-dd897c23a64a445db2ec608aecce5511
institution Kabale University
issn 2090-6404
2090-6412
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-dd897c23a64a445db2ec608aecce55112025-02-03T05:51:36ZengWileyCase Reports in Cardiology2090-64042090-64122017-01-01201710.1155/2017/69562986956298Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with HyoscyamineMohammad Saud Khan0Abhinav Tiwari1Zubair Khan2Himani Sharma3Mohammad Taleb4Jeffrey Hammersley5Department of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USADepartment of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USADepartment of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USADepartment of Internal Medicine, University of Toledo Medical Center, Toledo, OH, USADepartment of Internal Medicine and Department of Pulmonary/Critical Care, University of Toledo Medical Center, Toledo, OH, USADepartment of Internal Medicine and Department of Pulmonary/Critical Care, University of Toledo Medical Center, Toledo, OH, USAReversible acetylcholinesterase inhibitors are used as first-line treatment for myasthenia gravis. They improve symptoms by increasing concentration of acetylcholine at the neuromuscular junction and stimulating nicotinic receptors. Serious bradyarrhythmias can occur from muscarinic stimulation in heart, which in rare cases may progress to asystole. These patients can initially be managed with hyoscyamine, a muscarinic antagonist. Persistence of bradyarrhythmias even after hyoscyamine treatment may warrant pacemaker placement. We present a case of 65-year-old female patient who presented with diplopia, dysphagia, and muscle weakness who was diagnosed with myasthenia gravis. She developed significant sinoatrial node block with prolonged asystole after starting treatment with pyridostigmine which was successfully treated with hyoscyamine, thus avoiding pacemaker placement.http://dx.doi.org/10.1155/2017/6956298
spellingShingle Mohammad Saud Khan
Abhinav Tiwari
Zubair Khan
Himani Sharma
Mohammad Taleb
Jeffrey Hammersley
Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine
Case Reports in Cardiology
title Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine
title_full Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine
title_fullStr Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine
title_full_unstemmed Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine
title_short Pyridostigmine Induced Prolonged Asystole in a Patient with Myasthenia Gravis Successfully Treated with Hyoscyamine
title_sort pyridostigmine induced prolonged asystole in a patient with myasthenia gravis successfully treated with hyoscyamine
url http://dx.doi.org/10.1155/2017/6956298
work_keys_str_mv AT mohammadsaudkhan pyridostigmineinducedprolongedasystoleinapatientwithmyastheniagravissuccessfullytreatedwithhyoscyamine
AT abhinavtiwari pyridostigmineinducedprolongedasystoleinapatientwithmyastheniagravissuccessfullytreatedwithhyoscyamine
AT zubairkhan pyridostigmineinducedprolongedasystoleinapatientwithmyastheniagravissuccessfullytreatedwithhyoscyamine
AT himanisharma pyridostigmineinducedprolongedasystoleinapatientwithmyastheniagravissuccessfullytreatedwithhyoscyamine
AT mohammadtaleb pyridostigmineinducedprolongedasystoleinapatientwithmyastheniagravissuccessfullytreatedwithhyoscyamine
AT jeffreyhammersley pyridostigmineinducedprolongedasystoleinapatientwithmyastheniagravissuccessfullytreatedwithhyoscyamine